Old and new anti-obesity drugs

被引：0
作者：
Dodangeh, Salimeh [1 ]
Hasani-Ranjbar, Shirin [2 ]
机构：
[1] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Obes & Eating Habits Res Ctr, Tehran, Iran
来源：
JOURNAL OF DIABETES AND METABOLIC DISORDERS | 2024年 / 24卷 / 01期
关键词：
Obesity; Overweight; Anti-obesity medication; Weight loss medication; GLUCAGON-LIKE PEPTIDE-1; GLP-1 RECEPTOR AGONIST; WEIGHT-LOSS; CLINICAL ENDOCRINOLOGISTS; APPETITE SUPPRESSION; AMERICAN ASSOCIATION; EXTENDED-RELEASE; GENE-EXPRESSION; OBESE-PATIENTS; DOUBLE-BLIND;
D O I：
10.1007/s40200-024-01512-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Obesity is a pandemic problem that correlates with a cluster of metabolic factors leading to poor cardiovascular outcomes, morbidity, and an increased risk of overall mortality. It is necessary to approach obesity with a comprehensive treatment plan, which may involve lifestyle modifications (diet, exercise, and behavioral therapy) and pharmacological interventions. This article provides an overview of the mechanisms of action, efficacy, and safety of available long-term anti-obesity drugs and introduces other potential agents under investigation.
引用
收藏
页数：13
相关论文
共 81 条
  • [1] Pharmacotherapy for chronic obesity management: a look into the future
    Abdel-Malek, Mariana
    Yang, Lisa
    Miras, Alexander Dimitri
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2023, 18 (04) : 1019 - 1030
  • [2] Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake
    Adriaenssens, Alice E.
    Biggs, Emma K.
    Darwish, Tamana
    Tadross, John
    Sukthankar, Tanmay
    Girish, Milind
    Polex-Wolf, Joseph
    Lam, Brain Y.
    Zvetkova, Ilona
    Pan, Warren
    Chiarugi, Davide
    Yeo, Giles S. H.
    Blouet, Clemence
    Gribble, Fiona M.
    Reimann, Frank
    [J]. CELL METABOLISM, 2019, 30 (05) : 987 - +
  • [3] Mechanisms of Weight Loss After Obesity Surgery
    Akalestou, Elina
    Miras, Alexander D.
    Rutter, Guy A.
    le Roux, Carel W.
    [J]. ENDOCRINE REVIEWS, 2022, 43 (01) : 19 - 34
  • [4] Association of Pancreatitis with Glucagon-Like Peptide-I Agonist Use
    Anderson, Sarah L.
    Trujillo, Jennifer M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2010, 44 (05) : 904 - 909
  • [5] [Anonymous], About AutoCASE
  • [6] A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II)
    Apovian, Caroline M.
    Aronne, Louis
    Rubino, Domenica
    Still, Christopher
    Wyatt, Holly
    Burns, Colleen
    Kim, Dennis
    Dunayevich, Eduardo
    [J]. OBESITY, 2013, 21 (05) : 935 - 943
  • [7] Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
    Aronne, Louis J.
    Sattar, Naveed
    Horn, Deborah B.
    Bays, Harold E.
    Wharton, Sean
    Lin, Wen-Yuan
    Ahmad, Nadia N.
    Zhang, Shuyu
    Liao, Ran
    Bunck, Mathijs C.
    Jouravskaya, Irina
    Murphy, Madhumita A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (01): : 38 - 48
  • [8] Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
    Astrup, Arne
    Madsbad, Sten
    Breum, Leif
    Jensen, Thomas J.
    Kroustrup, Jens Peter
    Larsen, Thomas Meinert
    [J]. LANCET, 2008, 372 (9653) : 1906 - 1913
  • [9] Under-reporting of adverse effects of tesofensine
    Astrup, Arne
    Madsbad, Sten
    Breum, Leif
    Jensen, Thomas J.
    Kroustrup, Jens P.
    Larsen, Thomas M.
    [J]. LANCET, 2013, 382 (9887) : 127 - 127
  • [10] Tesofensine, a Novel Triple Monoamine Reuptake Inhibitor, Induces Appetite Suppression by Indirect Stimulation of α1 Adrenoceptor and Dopamine D1 Receptor Pathways in the Diet-Induced Obese Rat
    Axel, Anne Marie D.
    Mikkelsen, Jens D.
    Hansen, Henrik H.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2010, 35 (07) : 1464 - 1476
123456789